Place · Level 3 · Supplement
N-acetylcysteine (NAC)
FDA 批的对乙酰氨基酚解毒剂 · GSH 前体 · COPD 痰多有用 · 补 GSH营销陷阱
Story path
Chapter 1
Identity
Identity
N-acetylcysteine (NAC) = cysteine (Cys) with an acetyl group on the amino nitrogen.
Why not just take cysteine? Because oral cysteine is metabolized rapidly in the gut and liver, has a short plasma half-life, and can oxidize into the more toxic cystine. Acetylation is a protective coat for cysteine: once inside the cell, amidases strip the acetyl group off and release free cysteine.
NAC has a single core identity inside the body: a cysteine supplier.
What is cysteine? The rate-limiting raw material for the glutathione (GSH) tripeptide.
GSH = γ-Glu-Cys-Gly (a tripeptide of three amino acids, with an unusual γ-peptide bond)
Glutamate (Glu) — never scarce in the bodyGlycine (Gly) — never scarce in the bodyCysteine (Cys) — the rate-limiting raw material, because Cys is relatively scarce in the diet and the GSH pool is heavily consumed during oxidative stress and detoxification
So every "mechanism story" about NAC ultimately converges on one thing: raise the intracellular Cys pool so that GSH synthetase (GCL) has substrate to work with.
Why not just take cysteine? Because oral cysteine is metabolized rapidly in the gut and liver, has a short plasma half-life, and can oxidize into the more toxic cystine. Acetylation is a protective coat for cysteine: once inside the cell, amidases strip the acetyl group off and release free cysteine.
NAC has a single core identity inside the body: a cysteine supplier.
What is cysteine? The rate-limiting raw material for the glutathione (GSH) tripeptide.
GSH = γ-Glu-Cys-Gly (a tripeptide of three amino acids, with an unusual γ-peptide bond)
Glutamate (Glu) — never scarce in the bodyGlycine (Gly) — never scarce in the bodyCysteine (Cys) — the rate-limiting raw material, because Cys is relatively scarce in the diet and the GSH pool is heavily consumed during oxidative stress and detoxification
So every "mechanism story" about NAC ultimately converges on one thing: raise the intracellular Cys pool so that GSH synthetase (GCL) has substrate to work with.
Why oral GSH itself doesn't work
On the supplement market there are vendors selling "reduced glutathione (GSH) oral capsules" at 2-5× the price of NAC. But oral GSH barely makes it into the blood pool:GSH is a tripeptide — peptidases in the stomach and gut (γ-glutamyl-transpeptidase, peptidases) cut it back into three free amino acidsThose amino acids are then absorbed individually, and the cell rebuilds GSH from scratch — a long round trip with the same bottleneck at the end: Cys supplyMultiple PK studies (*Witschi 1992* *EJCP* and others): oral GSH produces only a small, short-lived rise in plasma GSH — far inferior to NAC
Conclusion: "oral GSH" is clever marketing, but the pharmacokinetics don't hold up. If you want to raise the cellular GSH pool, giving the cell Cys is more direct, cheaper, and more controllable than giving it GSH.
NAC is not an antioxidant itself — it is the raw-material supplement for the antioxidant (GSH). The distinction is constantly muddied in the supplement aisle, but once you understand it, products like "GSH capsules" stop being persuasive.
Chapter 2
GSH cycle
GSH cycle
GSH inside the cell is not "stored and spent once" — it runs as a synthesis + oxidation + reduction cycle:
1. Synthesis (two steps, adenosine triphosphate: The cell's universal energy currency — almost everything that costs energy spends it.-consuming)
GCL (γ-glutamylcysteine ligase, rate-limiting): Glu + Cys + ATP → γ-Glu-Cys + ADP + PiGSS (glutathione synthetase): γ-Glu-Cys + Gly + ATP → GSH + ADP + PiGCL is feedback-regulated by Cys concentration — this is exactly where NAC enters the story physically: raise Cys → relieve the GCL bottleneck → GSH synthesis rises
2. Oxidation (the antioxidant job)
GPx (glutathione peroxidase): 2 GSH + H₂O₂ → GSSG + 2 H₂OGSH neutralizes hydrogen peroxide, lipid peroxides, and various electrophilic toxins (such as NAPQI, covered in the next scene)During neutralization, GSH itself is oxidized to GSSG (the oxidized GSH dimer)
3. Reduction (closing the loop)
GR (glutathione reductase): GSSG + NADPH → 2 GSH + NADP⁺NADPH comes from the pentose phosphate pathway — so the GSH system indirectly depends on your glucose metabolism and G6PD enzyme activity (G6PD-deficient patients have to be careful with NAC, covered below)
Where NAC plugs in: at the Cys supply at the entrance of step 1. Every clinical use of NAC (poisoning antidote, COPD, psychiatry) amplifies the GSH pool through this same entry point.
Click "Take a closer look at this scene →" for the 4-step animation — the full GCL → GSS → GPx → GR cycle with NAC boosting the Cys pool at the entrance.
1. Synthesis (two steps, adenosine triphosphate: The cell's universal energy currency — almost everything that costs energy spends it.-consuming)
GCL (γ-glutamylcysteine ligase, rate-limiting): Glu + Cys + ATP → γ-Glu-Cys + ADP + PiGSS (glutathione synthetase): γ-Glu-Cys + Gly + ATP → GSH + ADP + PiGCL is feedback-regulated by Cys concentration — this is exactly where NAC enters the story physically: raise Cys → relieve the GCL bottleneck → GSH synthesis rises
2. Oxidation (the antioxidant job)
GPx (glutathione peroxidase): 2 GSH + H₂O₂ → GSSG + 2 H₂OGSH neutralizes hydrogen peroxide, lipid peroxides, and various electrophilic toxins (such as NAPQI, covered in the next scene)During neutralization, GSH itself is oxidized to GSSG (the oxidized GSH dimer)
3. Reduction (closing the loop)
GR (glutathione reductase): GSSG + NADPH → 2 GSH + NADP⁺NADPH comes from the pentose phosphate pathway — so the GSH system indirectly depends on your glucose metabolism and G6PD enzyme activity (G6PD-deficient patients have to be careful with NAC, covered below)
Where NAC plugs in: at the Cys supply at the entrance of step 1. Every clinical use of NAC (poisoning antidote, COPD, psychiatry) amplifies the GSH pool through this same entry point.
Click "Take a closer look at this scene →" for the 4-step animation — the full GCL → GSS → GPx → GR cycle with NAC boosting the Cys pool at the entrance.
G6PD caveat
G6PD (glucose-6-phosphate dehydrogenase) deficiency is a relatively common inherited deficiency in people of African, Mediterranean, and Southeast Asian ancestry — and it primarily affects red blood cells.Mechanism: G6PD is the rate-limiting enzyme of the pentose phosphate pathway → produces NADPH → red cells use NADPH to keep the GR / GSH reduction cycle running → which keeps the antioxidant protection of the red cell membrane intact.
G6PD deficiency → NADPH supply cannot keep up → red cell GSH pool falls → red cell oxidative damage + hemolytic anemia.
The relationship with NAC:
NAC itself is not the problem — it raises the Cys pool, supplying more substrate for GSH synthesis, which is in principle helpfulBut NAC's metabolic byproducts can trigger oxidative stress in certain individuals, because GSH is consumed into GSSG while neutralizing ROS, and then has to be reduced back by NADPHG6PD deficiency → insufficient NADPH → GSSG accumulates → red cell oxidative damageSo G6PD-deficient patients using NAC (especially high-dose intravenous, in clinical antidote scenarios) must be monitored by a physician, and should not self-administer high-dose OTC NAC long-term
This is the real-world price of a mechanistically clear supplement — it really does move your biochemistry, so it really can hurt you. This is the opposite of the "mechanistically vague placebo supplement": the latter doesn't hurt you, but it doesn't help you either.
Self-screen checklist: is your ancestry Mediterranean / Middle Eastern / African / Southeast Asian? Have you ever had unexplained jaundice or a fava bean (favism) reaction? If so, test G6PD activity before taking NAC.
Chapter 3
Paracetamol antidote
Paracetamol antidote
NAC is the FDA-approved antidote for paracetamol (acetaminophen / Tylenol) overdose — this is its most solid clinical identity.
Toxicology chain:
1. At therapeutic doses (< 4 g/day), paracetamol is mostly handled by hepatic glucuronidation and sulfation — benign pathways
2. With overdose (a single dose > 10 g, or sustained 4-6 g/day with alcohol use / malnutrition), the benign pathways saturate and the excess drug is oxidized by CYP2E1 to NAPQI — a reactive electrophilic toxin
3. NAPQI is immediately neutralized by hepatic GSH — no harm done
4. But if large amounts of NAPQI keep being generated → GSH pool runs out → unbound NAPQI covalently binds liver proteins → massive centrilobular hepatocyte necrosis → acute liver failure → death or emergency liver transplant
How NAC rescues:
NAC → raises the Cys pool → GCL accelerates GSH synthesis → GSH pool is rapidly rebuiltThis races NAPQI before it destroys the liver → continues neutralizing NAPQI → hepatocytes are spared
Clinical facts:
Prescott 1976 *Lancet* — the first published clinical case report: intravenous NAC for paracetamol overdose changed the mortality curveRumack 1981: 662 cases treated with oral NAC; when given within 8-10 hours of ingestion, severe hepatotoxicity dropped from over 50% to under 5%Rumack-Matthew nomogram: the emergency clinical decision tool — plot serum drug level against time; if the point is above the line, give NACFDA approvals: oral NAC (Mucomyst) in 1985; intravenous (Acetadote) in 2004
Acetaminophen remains the leading cause of acute liver failure in the US (~50% of cases). NAC is the only validated tool standing between that mortality curve and the patient.
This is one of the rare "this molecule actually saves lives"-grade evidence findings in the supplement world.
Toxicology chain:
1. At therapeutic doses (< 4 g/day), paracetamol is mostly handled by hepatic glucuronidation and sulfation — benign pathways
2. With overdose (a single dose > 10 g, or sustained 4-6 g/day with alcohol use / malnutrition), the benign pathways saturate and the excess drug is oxidized by CYP2E1 to NAPQI — a reactive electrophilic toxin
3. NAPQI is immediately neutralized by hepatic GSH — no harm done
4. But if large amounts of NAPQI keep being generated → GSH pool runs out → unbound NAPQI covalently binds liver proteins → massive centrilobular hepatocyte necrosis → acute liver failure → death or emergency liver transplant
How NAC rescues:
NAC → raises the Cys pool → GCL accelerates GSH synthesis → GSH pool is rapidly rebuiltThis races NAPQI before it destroys the liver → continues neutralizing NAPQI → hepatocytes are spared
Clinical facts:
Prescott 1976 *Lancet* — the first published clinical case report: intravenous NAC for paracetamol overdose changed the mortality curveRumack 1981: 662 cases treated with oral NAC; when given within 8-10 hours of ingestion, severe hepatotoxicity dropped from over 50% to under 5%Rumack-Matthew nomogram: the emergency clinical decision tool — plot serum drug level against time; if the point is above the line, give NACFDA approvals: oral NAC (Mucomyst) in 1985; intravenous (Acetadote) in 2004
Acetaminophen remains the leading cause of acute liver failure in the US (~50% of cases). NAC is the only validated tool standing between that mortality curve and the patient.
This is one of the rare "this molecule actually saves lives"-grade evidence findings in the supplement world.
Why mixing Tylenol + alcohol is bad
Alcohol + paracetamol = NAPQI production doubly amplified:Long-term or heavy drinking → CYP2E1 is induced (upregulated 3-10×) — this is the liver's main alcohol-handling enzyme, but it is also the enzyme that converts paracetamol into NAPQIAt the same time, drinking and alcoholic liver disease typically lower baseline GSH pool (oxidative stress consumes it + Cys / protein intake may be inadequate)The double hit: more NAPQI generated + less GSH to neutralize it → hepatotoxicity at "therapeutic doses"
Clinical warnings:
Chronic drinkers should not exceed 2 g paracetamol per dayAcute intoxication + a headache treated with 4-8 g Tylenol → a real-life ER fatality scenario"I just took a pill for a headache" + "I had a few drinks last night" — these two statements together are routinely underestimated
Practical:
Before or after a single heavy-drinking session, choose ibuprofen / aspirin (NSAID risk is a different category: GI bleeding) rather than Tylenol — but NSAIDs are also not harmless at high doses or long-termFor a chronic drinker with headaches: see a physician for proper evaluationDo not take NAC daily "to prevent hangovers": there is no reliable RCT evidence supporting this, and it may dull your awareness of how much you are drinking. NAC is a rescue tool, not a permission slip.
Chapter 4
Other uses
Other uses
Outside the paracetamol antidote, NAC has real but tiered evidence in two completely different domains:
1. Chronic airway mucolytic (COPD / chronic bronchitis)
NAC carries a free -SH (thiol) groupThe mucin glycoproteins in airway sputum form a thick elastic gel through disulfide bridgesNAC's -SH can open those disulfide bridges, thinning the mucus and making it easier to clearCazzola 2015 *ERR* meta-analysis: 13 RCTs combined; high-dose NAC (1200 mg/day) reduced COPD exacerbations (annual rate ratio 0.75), significantly better than placeboCentral Europe / Italy / Spain prescribe it routinely in chronic COPD management; the US uses it less because inhaled bronchodilators + corticosteroids are more mainstreamEvidence level: B-A, applicable to patients with diagnosed COPD
2. Psychiatry
NAC has been studied across multiple psychiatric indications because psychiatric illness and oxidative stress + glutamatergic system imbalance share part of their pathophysiology:
OCD / trichotillomania / skin-picking disorder: multiple small RCTs show NAC 2400 mg/day reduces compulsive behaviors (*Smaga 2021* *BJP* review)Bipolar disorder / depression adjunct: small, inconsistent signals — not a mainstream recommendationSubstance addiction (cocaine / cannabis / nicotine) reduction: some small RCTs show reduced craving; the mechanism may involve modulation of the cystine-glutamate antiporterSchizophrenia cognitive symptom adjunct: emerging signal, awaiting large replications
Evidence level: B-C, these are all adjunctive evidence — not standalone first-line therapy.
3. When NAC is not appropriate:
G6PD deficiency (covered above)Acute asthma exacerbation: nebulized NAC can paradoxically trigger bronchospasm (because it temporarily increases mucus and irritates the airway)Chronic anticoagulant therapy (warfarin etc.) + long-term high-dose NAC: reports of slight INR rise — monitoring is requiredPregnancy / breastfeeding: data are limited (note: IV NAC for paracetamol overdose in pregnant women is a different matter — that is a rescue scenario)
1. Chronic airway mucolytic (COPD / chronic bronchitis)
NAC carries a free -SH (thiol) groupThe mucin glycoproteins in airway sputum form a thick elastic gel through disulfide bridgesNAC's -SH can open those disulfide bridges, thinning the mucus and making it easier to clearCazzola 2015 *ERR* meta-analysis: 13 RCTs combined; high-dose NAC (1200 mg/day) reduced COPD exacerbations (annual rate ratio 0.75), significantly better than placeboCentral Europe / Italy / Spain prescribe it routinely in chronic COPD management; the US uses it less because inhaled bronchodilators + corticosteroids are more mainstreamEvidence level: B-A, applicable to patients with diagnosed COPD
2. Psychiatry
NAC has been studied across multiple psychiatric indications because psychiatric illness and oxidative stress + glutamatergic system imbalance share part of their pathophysiology:
OCD / trichotillomania / skin-picking disorder: multiple small RCTs show NAC 2400 mg/day reduces compulsive behaviors (*Smaga 2021* *BJP* review)Bipolar disorder / depression adjunct: small, inconsistent signals — not a mainstream recommendationSubstance addiction (cocaine / cannabis / nicotine) reduction: some small RCTs show reduced craving; the mechanism may involve modulation of the cystine-glutamate antiporterSchizophrenia cognitive symptom adjunct: emerging signal, awaiting large replications
Evidence level: B-C, these are all adjunctive evidence — not standalone first-line therapy.
3. When NAC is not appropriate:
G6PD deficiency (covered above)Acute asthma exacerbation: nebulized NAC can paradoxically trigger bronchospasm (because it temporarily increases mucus and irritates the airway)Chronic anticoagulant therapy (warfarin etc.) + long-term high-dose NAC: reports of slight INR rise — monitoring is requiredPregnancy / breastfeeding: data are limited (note: IV NAC for paracetamol overdose in pregnant women is a different matter — that is a rescue scenario)
NAC and COVID — what the data show
During 2020-2022, NAC was heavily marketed online as an "anti-COVID miracle drug":The hypothesis: NAC → raises GSH → blunts oxidative stress + reduces cytokine storm + helps mucus clearancePushed by early social media, podcasts (e.g. Joe Rogan), iHerb and Amazon NAC sales explodedThe FDA briefly tried in 2022 to remove NAC from supplement classification (because of its FDA-approved drug use), then reversed course
The clinical evidence truth:
Multiple small RCTs gave mixed signals, with no consistent improvement in hard endpoints (hospitalization / ICU / death)Large meta-analyses: in mild COVID, NAC shows no clinically meaningful reduction in survival or admissionWHO / NIH / CDC: do not recommend NAC as a standard COVID treatment
This episode is worth remembering: NAC is a genuinely useful molecule, but "useful" is not the same as "universal". Pushing it as a miracle drug in a new context without strong evidence is standard supplement marketing — plausible mechanism → media amplification → sales boom → large RCT contradicts → marketing quietly moves to the next molecule.
This is why the atlas keeps emphasizing: a clear mechanism does not guarantee clinical efficacy. NAC is grade A for paracetamol; B-A for COPD; B for OCD; D for COVID. Evaluating a supplement is not the same as evaluating a molecule — it is evaluating that molecule's performance in that specific context.
Chapter 5
Decision tree
Decision tree
Do you need NAC?
Q1: What's your situation?
Acute paracetamol overdose (intentional or accidental) → go to the emergency room immediately, do not try NAC at home (dose, time window, and monitoring all have to be clinical)Diagnosed COPD / chronic bronchitis → discuss 600-1200 mg/day NAC with your pulmonologist; it may reduce exacerbationsOCD / trichotillomania / skin-picking disorder → discuss NAC 2400 mg/day with your psychiatrist as an adjunct (not a replacement for standard treatment)Healthy person wanting general "antioxidant / anti-aging" → evidence is insufficient, not a priority — see Q2 belowChronic drinker who occasionally takes paracetamol → don't try to "prevent" with NAC; limit alcohol and drug dose directly
Q2: Do you want to take NAC for "wellness"?
There is no human hard-endpoint evidence (lifespan / CVD / cancer) supporting long-term NAC in healthy peopleSmall RCT signals: short-term raises in GSH pool with improvements in some oxidative markers, but clinical endpoints are nullSide effects: GI discomfort (10-20%), rare allergy, long-term high-dose + anticoagulation / G6PD risksIf you insist on trying it: 600 mg/day for 1-3 months, watch the response, don't stack multiple "antioxidant supplements"
Q3: Dose selection:
600 mg/day — general maintenance1200 mg/day — COPD clinical dose2400 mg/day — psychiatric research dose (divided)6000 mg + IV, emergency — clinical settings only
Q4: People who should not self-purchase:
G6PD-deficient ancestry (Mediterranean / Middle Eastern / African / Southeast Asian), untested G6PDActive chronic asthmaContinuous anticoagulant therapyPregnancy / breastfeeding"I caught a cold and want to fight the virus" — the evidence isn't there; water + rest + vitamin C / zinc are also B-C grade, but cheaper
Cost-effectiveness: 600 mg × 60 caps ≈ $10-15/month — far better value than GSH capsules.
Q1: What's your situation?
Acute paracetamol overdose (intentional or accidental) → go to the emergency room immediately, do not try NAC at home (dose, time window, and monitoring all have to be clinical)Diagnosed COPD / chronic bronchitis → discuss 600-1200 mg/day NAC with your pulmonologist; it may reduce exacerbationsOCD / trichotillomania / skin-picking disorder → discuss NAC 2400 mg/day with your psychiatrist as an adjunct (not a replacement for standard treatment)Healthy person wanting general "antioxidant / anti-aging" → evidence is insufficient, not a priority — see Q2 belowChronic drinker who occasionally takes paracetamol → don't try to "prevent" with NAC; limit alcohol and drug dose directly
Q2: Do you want to take NAC for "wellness"?
There is no human hard-endpoint evidence (lifespan / CVD / cancer) supporting long-term NAC in healthy peopleSmall RCT signals: short-term raises in GSH pool with improvements in some oxidative markers, but clinical endpoints are nullSide effects: GI discomfort (10-20%), rare allergy, long-term high-dose + anticoagulation / G6PD risksIf you insist on trying it: 600 mg/day for 1-3 months, watch the response, don't stack multiple "antioxidant supplements"
Q3: Dose selection:
600 mg/day — general maintenance1200 mg/day — COPD clinical dose2400 mg/day — psychiatric research dose (divided)6000 mg + IV, emergency — clinical settings only
Q4: People who should not self-purchase:
G6PD-deficient ancestry (Mediterranean / Middle Eastern / African / Southeast Asian), untested G6PDActive chronic asthmaContinuous anticoagulant therapyPregnancy / breastfeeding"I caught a cold and want to fight the virus" — the evidence isn't there; water + rest + vitamin C / zinc are also B-C grade, but cheaper
Cost-effectiveness: 600 mg × 60 caps ≈ $10-15/month — far better value than GSH capsules.
Stack priority
If you want to "fight oxidation", this is the easiest rabbit hole in the supplement aisle — the market is full of GSH / NAC / vitamin E / vitamin C / alpha-lipoic acid / coenzyme Q10 / quercetin / curcumin / resveratrol / pterostilbene...First, recognize this fact: multiple large RCTs (HOPE, SELECT, chemoprevention trials) have shown that single high-dose antioxidant supplements are ineffective on hard endpoints (cardiovascular, cancer, mortality), and can even be slightly harmful. This is the lesson covered in the vitamin-e scene of the atlas: "perfect mechanism → RCTs wipe out completely".
The real "antioxidant strategy", ranked by ROI:
1. Don't smoke + drink less — the largest source of oxidative stress
2. Get 7-9 hours of sleep — GSH pool is rebuilt overnight
3. Eat varied vegetables and fruit daily (400-500 g) — you take in the whole polyphenol + carotenoid + vitamin C matrix, which is closer to the clinical evidence than any single-molecule supplement
4. Regular aerobic + resistance training — upregulates the endogenous antioxidant system (NRF2 pathway), more sustainable than external antioxidant supplementation
5. If you have a specific indication (paracetamol / COPD / OCD) — NAC is one of the few items on the recommended list, because it targets the GSH system, which is the antioxidant hub
6. If items 1-5 are already in place and you want to add one more thing — NAC 600 mg/day for a period, and watch yourself for a real difference
What you should not stack:
NAC + oral GSH + cystine powder + high-dose vitamin E + ALA + CoQ10 + ... — swallowing an antioxidant salad does not make you more antioxidant; it interferes with physiologic ROS signaling (exercise adaptation and immune responses both require ROS signals)
Bottom line: the antioxidant system is the body's own finely-tuned feedback network. Your job is not to shovel raw materials in from outside — it is to not break the system.